Many funds have two different versions and picking the right one can have a big impact on your investment returns but also on your tax...

For years many investors have viewed Amazon (AMZN:NASDAQ) as an undefeatable business that can do no wrong. Wherever it moved in the retail space, success...

Global investors had been hoping that big tech earnings would put the brakes on sliding stock markets, but it hasn’t quite worked out that way....

In an inflationary environment buying an investment trust which offers exposure to both cheap equities and alternative assets like infrastructure which have inflation protection looks...

A new study by Which? has found nearly one in 10 people (8%) are taking out new credit cards to cope with the cost-of-living crisis. Moneysupermarket (...

I’m being automatically enrolled into a workplace pension scheme and was told this would be 8% of my salary. However, I’ve just done the sums...

GlaxoSmithKline (GSK) £17.96

Gain to date: 36%

Original entry point: Buy at £13.21 on 5 November 2020

Investor sentiment towards GlaxoSmithKline...

FIDELITY SPECIAL VALUES (FSV) 283.5p

Loss to date: 7.5%

Original entry point: Buy at 306.6p, 11 November 2021

We remain positive on Fidelity...

Even $20.4 billion worth of write-offs linked to BP’s (BP) exit from Russia couldn’t obscure the strong first quarter enjoyed by the company.

The non-cash impairments principally...

Drax (DRX) 811p

Gain to Date: 21.6%

Original entry point: Buy at 667p on 10 March 2022

It is pleasing to...